NOVEL TREATMENT OF DIABETIC FOOT ULCER BY AUTOLOGOUS STROMAL VASCULAR FRACTION OF ADIPOSE TISSUE: PHASE II OPEN-ENDED, MULTI-CENTRE STUDY (REGENDER)

Status

Not yet recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516342-19-00

Enrollment

Registered

2024-09-13

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot ulcERs

Brief summary

percentage (%) of wounds completely healed by week 20 (S20) post-injection

Interventions

DRUGSVF

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
percentage (%) of wounds completely healed by week 20 (S20) post-injection	—

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026